期刊文献+

肺腺癌新分类在预测Ⅰb期非小细胞肺癌预后中的价值 被引量:1

The Predictive Value of New Lung Adenocarcinoma Classification on the Prognosis of Non-small Cell Lung Cancer Stage Ⅰb
原文传递
导出
摘要 [目的]探讨新的肺腺癌分类在判断早期可手术的Ⅰb期非小细胞肺腺癌患者中的预后价值。[方法]回顾性分析168例非小细胞肺癌患者,根据第7版TNM分期明确诊断为Ⅰb期非小细胞肺腺癌。采用Kaplan-Meier法比较不同病理亚型患者的无复发生存期和总生存期。Cox回归分析探讨影响患者无复发生存期和总生存期的影响因素。[结果]168例患者中,无原位腺癌患者,2例患者为微浸润腺癌,51例患者为乳头状为主型,55例患者为腺泡样为主型,24例为微乳头为主型,20例为鳞屑状为主型,12例为实性为主型腺癌,4例为变异性腺癌(其中2例为实性腺癌,2例为胎儿型腺癌)。单因素分析显示,是否淋巴管/血管侵犯(P=0.042)和不同病理类型(P=0.004)是影响患者5年无复发生存的因素。多因素分析显示,病理类型是同时影响患者5年无复发生存和总生存期的惟一因素(P分别为0.002和0.035)。[结论]新肺腺癌分类在预测可手术的Ⅰb期非小细胞肺腺癌的无复发生存和总生存方面有一定的价值。 [ Purpose ] To investigate the relationship between new Lung Adenocarcinoma Classification and prognosis of lung adenocarcinoma stage Ⅰb. [Methods] One hundred and sixtyeight patients with stage I lung adenocarcinoma operated in Peking University Shougang Hos- pital,were identified between 2000 and 2010. Survival curves were plotted using the Kaplan- Meier method. The Cox proportional hazard model was used for multivariate analysis. [Results] None of the cases were adenocarcinoma in situ and two were minimally invasive adenocarcinomas. One hundred and sixty-six cases were invasive adenocarcinoma. Of those,51,55,24,12,20 and 4 were papillary predominant,acinar predominant,micropapillary predominant,solid predomi- nant,lepidic predominant subtypes, and variants of invasive adenocarcinoma,respectively. Pa- tients with micropapillary and solid predominant tumors had a significantly worse disease-free survival as compared to those with other subtypes predominant tumors (P〈0.001). Multivariate analysis revealed that the new classification was an independent predictor of the disease-free and overall survival (P=-0.002 and 0.035). [Conclusion] The predominant subtype in the primary tumor is associated with prognosis of resected lung adenocarcinoma stage Ⅰ.
出处 《肿瘤学杂志》 CAS 2014年第6期448-451,共4页 Journal of Chinese Oncology
关键词 非小细胞肺 腺癌新分类 预后 NSCLC IASLC/ATS/ERS classification prognosis
  • 相关文献

参考文献14

  • 1Siegel R,Ward E,Brawley O,et al. Cancer statistics 2011 [J]. C A Cancer J Clin, 2011,61 (4) : 212-236. 被引量:1
  • 2Hung JJ,Jeng WJ,Hsu WH,et al. Predictors of death,lo- cal recurrence,and distant metastasis in completely re- sected pathological stage- I non-small-cell lung cancer[J]. J Thorac Onco1,2012,7 (7): 1115-1123. 被引量:1
  • 3Maeda R,Yoshida J,Ishii G,et al. Prognostic factors in patients with stage Ⅰ B non-small cell lung cancer according to the seventh edition TNM classification [J].Chest, 2011,139 (4):855-861. 被引量:1
  • 4Wang M,Zhao J,Pan Y,et al. Do tumor cavitation and sex in resected stage I non-small-cell lung cancer correlate with prognosis?[J]. World J Surg, 2009,33(3) :497-504. 被引量:1
  • 5Shimada Y,Saji H,Yoshida K,et al. Pathological vascular invasion and tumor differentiation predict cancer recur- rence in stage I A non-small-cell lung cancer after com- plete surgical resection [J]. J Thorac Oncol,2012,7(8): 1263-1270. 被引量:1
  • 6Maeda R,Yoshida J,Hishida T,et al. Late recurrence of non-small cell lung cancer more than 5 years after com- plete resection: incidence and clinical implications in patient follow-up[J]. Chest, 2010, 138(5) : 145-150. 被引量:1
  • 7Travis WD,Brambilla E,Noguchi M,et al. The new IASLC/ATS/ERS international muhidisciplinary lung adenocarcino- ma classification[J]. J Thoracic Oncol,2011,6 (2):244-285. 被引量:1
  • 8Song Z,Zhu H,Guo Z,et al. Prognostic value of the IASLC/ ATS/ERS classification in stage Ⅰ lung adenocarcinoma patients-based on a hospital study in China [J]. Eur J Surg Oncol,2013,3(11): 1262-1268. 被引量:1
  • 9Woo T, Okudela K, Mitsui H, et al. Prognostic value of the IASLC/ATS/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases [J]. Pathol Int,2012,62 (12) :785-791. 被引量:1
  • 10Yoshizawa A,Sumiyoshi S,Sonobe M,et al. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients [J]. J Thorac Oncol,2013,8 (1):52-61. 被引量:1

同被引文献6

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部